Michael Zhou, Ph.D. has been appointed senior director of research and development at Bioanalytical Systems Inc. (BASi). Dr. Zhou will guide the method development program and will lead the company’s discovery bioanalytical support group.

Dr. Zhou joins the company from Synta Pharmaceuticals Corp., where he served as director of bioanalytical chemistry/DMPK. He has expertise in analytical/bioanalytical operations and regulatory compliance, including GLP, cGMP, GCP regulations and ICH, GCLP, BMV guidelines. He has authored more than 50 research articles.

“Michael’s experience will consolidate our already strong reputation for developing the more challenging bioanalytical methods. In his R&D role, Michael will evaluate and implement new cost effective approaches to our bioanalytical process that will accelerate our growth and profitability,” said president and chief executive officer Anthony S. Chilton, Ph.D. “We will increase our international exposure as Michael represents us in industry conferences, meetings and workshops.”